Showing results (541-550 of 560) with videos related to

Sort By:
Pageof 56
European Journal of Cancer (Oxford, England : 1990)|September 5, 2024
Efficacy of anti PD-1 therapy in children and adolescent melanoma patients (MELCAYA study)Mario Mandalà, Andrea Ferrari, Ines B Brecht, et al.
Journal of Assisted Reproduction and Genetics|September 15, 2023
The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilizationI Feferkorn, S Santos-Ribeiro, F M Ubaldi, et al.
Journal for Immunotherapy of Cancer|June 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanomaJames William Smithy, Allison Betof, Sebastian Klobuch, et al.
Reproductive Biology and Endocrinology : RB&E|May 15, 2020
COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical managementCarlo Alviggi, Sandro C Esteves, Raoul Orvieto, et al.
JCO Global Oncology|February 4, 2021
Five-Year Cancer Epidemiology at the National Referral Hospital: Hospital-Based Cancer Registry Data in IndonesiaSoehartati Gondhowiardjo, Nadia Christina, Ngakan P D Ganapati, et al.
Journal of Gynecology Obstetrics and Human Reproduction|November 7, 2020
Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkersCyrille Huchon, Nicolas Bourdel, Cendos Abdel Wahab, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 2, 2020
Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF)N Bourdel, C Huchon, C Abdel Wahab, et al.
European Journal of Cancer (Oxford, England : 1990)|June 7, 2019
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancersChristine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Journal of Gynecology Obstetrics and Human Reproduction|November 4, 2020
Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservationNicolas Bourdel, Cyrille Huchon, Cendos Abdel Wahab, et al.
Bulletin Du Cancer|February 6, 2018
[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer]Christine Rousset-Jablonski, Fréderic Selle, Elodie Adda-Herzog, et al.
Pageof 56